Metaxalone (Skelaxin®)-related death

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 537-540

  Poklis, Justin L ^a   Ropero Miller, Jeri D ^a   Garside, Diana ^a   Winecker, Ruth E ^a  

^a Office of the Chief Medical Examiner (North Carolina)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DIAZEPAM; HYDROCODONE; METAXALONE; NORDAZEPAM; NORTRIPTYLINE; PARACETAMOL; CENTRAL MUSCLE RELAXANT; OXAZOLIDINONE DERIVATIVE;

ACUTE TOXICITY; ADULT; CASE REPORT; CAUSE OF DEATH; CONFERENCE PAPER; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; DRUG OVERDOSE; DRUG URINE LEVEL; EXTRACTION; FATALITY; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; STOMACH CONTENT; VITREOUS BODY; ARTICLE; GAS CHROMATOGRAPHY; INTOXICATION; MALE; MASS FRAGMENTOGRAPHY; STANDARD; SUICIDE; TISSUE DISTRIBUTION;

ADULT; CHROMATOGRAPHY, GAS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; OVERDOSE; OXAZOLIDINONES; REFERENCE STANDARDS; SUICIDE; TISSUE DISTRIBUTION;

EID: 4344652632     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.537     Document Type: Conference Paper

References (10)

1. A.C. Gruszecki, S. Kloda, G.T. Simmons, T.M. Daly, R.W. Hardy, and C.A. Robinson. Polydrug fatality involving metaxalone. J. Forensic Sci. 48: 432-434 (2003).
2. D. Nissen, Ed. Mosby's Drug Consult & Trade, 13th ed. Mosby, Inc., St. Louis, MO, 2003.
3. Physicians' Desk Reference, 58th ed. Medical Economics Co., Montvale, NJ, 2004, p 2181.
4. R.B. Bruce, L. Turnbull, J. Newman, and J. Pitts. Metabolism of metaxalone. J. Med. Chem. 99: 286-288 (1966).
5. R.W. Dent, Jr. and D.K. Ervin. A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study. Curr. Ther. Res. 18: 433-440 (1975).
6. K. Fathie. A second look at a skeletal muscle relaxant: a double-blind study of metaxalone. Curr. Ther. Res. 11: 677-683 (1964).
7. T. Kious, P. Wax, and D. Cobaugh. Tramadol and fluoxetine induced serotonin syndrome with subsequent severe hyperpyrexia despite cyproheptadine. J. Toxicol. Clin. Toxicol. 37: 631-632 (1999).
8. W.H. Anderson and D. C. Fuller. A simplified procedure for the isolation, characterization, and identification of weak acid and neutral drugs from whole blood. J. Anal. Toxicol. 11: 198-204 (1987).
9. A. Poklis, J.L. Poklis, D. Trautman, C. Treece, R. Backer, and C.M. Harvey. Dispostion of valproic acid in a case of fatal intoxication. J. Anal. Toxicol. 22: 537-540 (1998).
10. R.C. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 6th ed. Biomedical Publications, Foster City, CA, 2002, pp 519-521.